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Abstract
Background: There are well-documented treatment gaps in secondary prevention of coronary heart disease and
no clear guidelines to assist early physical activity after acute coronary syndromes (ACS). Smartphone technology
may provide an innovative platform to close these gaps. This paper describes the study design of a randomized
controlled trial assessing whether a smartphone-based secondary prevention program can facilitate early physical
activity and improve cardiovascular health in patients with ACS.
Methods: We have developed a multi-faceted, patient-centred smartphone-based secondary prevention program
emphasizing early physical activity with a graduated walking program initiated on discharge from ACS admission.
The program incorporates; physical activity tracking through the smartphone’s accelerometer with interactive feedback
and goal setting; a dynamic dashboard to review and optimize cardiovascular risk factors; educational messages
delivered twice weekly; a photographic food diary; pharmacotherapy review; and support through a short message
service. The primary endpoint of the trial is change in exercise capacity, as measured by the change in six-minute walk
test distance at 8-weeks when compared to baseline. Secondary endpoints include improvements in cardiovascular risk
factor status, psychological well-being and quality of life, medication adherence, uptake of cardiac rehabilitation
and re-hospitalizations.
Discussion: This randomized controlled trial will use a smartphone-phone based secondary prevention program
to emphasize early physical activity post-ACS. It will provide evidence regarding the feasibility and utility of this
innovative platform in closing the treatment gaps in secondary prevention.
Trial registration: The trial was retrospectively registered in the Australian New Zealand Clinical Trials Registry
(ANZCTR) on April 4, 2016. The registration number is ACTRN12616000426482.
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Background
Coronary heart disease (CHD) is the leading cause of
mortality and morbidity in the world [1]. In 2012 CHD
accounted for approximately 7.4 million lives, an increase
of 23 % (1.4 million) from CHD deaths in 2000 [1]. Pa-
tients at highest risk of premature death, myocardial
infarction and re-hospitalization are those with known
CHD [2]. Consequently international guidelines strongly
advocate proven secondary prevention strategies such
evidence-based pharmacological therapy, cardiovascular
risk factor optimization, cardiac rehabilitation and adher-
ence to diet and physical activity recommendations [3].
Cardiac rehabilitation provides a comprehensive second-
ary prevention framework based on extensive scientific
evidence. A recent Cochrane review revealed cardiac
rehabilitation was associated with a 13 % decrease in
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all-cause mortality and a 26 % decrease in cardiovascu-
lar mortality [4]. This result is consistent with several
other meta-analyses [5–7].
However, there is poor translation of scientific evidence
into clinical practice. Cardiac rehabilitation services are
underutilized as highlighted by low referral rates and even
lower completion rates [8–12]. In addition, utilization of
recommended pharmacological therapy and compliance
with dietary and physical activity guidelines is suboptimal
[13–16]. Lastly, outpatient cardiac rehabilitation often
starts weeks to months after the index event, even with
the utilization of new technology [17]. This delay cre-
ates a missed opportunity to immediately reinforce the
importance of physical activity and lifestyle changes.
Furthermore, the delay in cardiac rehabilitation has
been associated with delayed resumption of work [18].
The drawbacks of conventional cardiac rehabilitation
have resulted in the development of innovative models
of care. In the seminal paper by Vale et al, regular personal
coaching via telephone has been shown to be effective in
reducing total cholesterol levels and other cardiovascular
risk factors [19]. Systematic reviews and meta-analyses
have shown telehealth interventions for secondary preven-
tion, limited to telephone calls, internet and videoconfer-
encing technologies, offer an effective alternative model of
secondary prevention care [20, 21].
Most recently, the Tobacco, Exercise and Diet Messages
(TEXT ME) study showed a lifestyle-focused text-messaging
service lowered LDL-cholesterol level, and blood pressure
while increasing smoking cessation rates and physical activ-
ity in patients with known CHD [22].
Smartphone technology is an advance on previous
telehealth and text-message based technologies. It has
the potential to revolutionize the landscape of secondary
prevention as it can provide a platform for a patient-
centred program with the capacity to incorporate edu-
cation, real-time feedback, motivation, reminders and
support. Furthermore, it is a tool that can be used to
monitor diet, physical activity, medications and cardiovas-
cular risk factor parameters. Lastly and most importantly,
a smartphone-based program can be started immediately,
delivered from anywhere at any time and for extended
periods of time.
Four studies have been published incorporating smart-
phone technology for the delivery of cardiac rehabilitation.
Worringham et al. assessed a walking-based cardiac re-
habilitation program with single-lead ECG, heart rate and
GPS-based speed and location transmitted via smartphone
for real-time monitoring by a qualified exercise scien-
tist. [23] Six patients were evaluated in 134 exercise
sessions with improvements in exercise capacity (im-
provement in 6-minute walk test from 524 m to 637 m,
p < 0.01) and health status measured by SF-36 form.
Korzeniowska-Kubacka et al. assessed a mobile device
with preprogrammed exercise training sessions with audio
and visual clues and a 3-lead ECG monitor [24]. In this
non-randomized trial, 30 patients were assigned to the
mobile device intervention with 10 supervised exercise
sessions and 14 sessions with the mobile device at home.
The control group of 32 patients had 24 supervised ex-
ercise sessions. There was in improvement in exercise
capacity in the mobile arm (p < 0.05) but no difference
in blood pressure. Blasco et al. assessed a web-based
telemonitoring system that provided patients with self-
measurement devices and connected them to a cardiolo-
gist who accessed the data and sent recommendations via
short message service (SMS) [25]. In this single-blinded,
randomized controlled trial of 203 acute coronary syn-
drome survivors, patients in the telemonitoring group
were more likely to improve at least one risk factor (RR
1.4, 95 % CI 1.1–1.7) and achieve targets for BP (62.1 % vs
42.9 %, p = 0.01) and HbA1c (86.4 % vs 54.2 %, p = 0.02).
Varnfield et al. compared the effectiveness of smartphone-
based cardiac rehabilitation versus traditional care on car-
diac rehabilitation uptake, adherence and completion in a
randomized controlled trial [17]. 120 patients were ran-
domized to the two groups for a 6-week cardiac rehabili-
tation program followed by a 6-month self-
maintenance period. The smartphone based model in-
cluded health and exercise monitoring, motivational
and educational material delivery and weekly mentoring
consultations. The trial met its primary end point with
the smartphone based rehabilitation program showing
significantly higher uptake (94 % vs. 68 %, P <0.05) and
completion (80 % vs. 47 %, p <0.05).
The exponential growth and availability of smartphone
technology provides a novel opportunity to optimize
secondary prevention of coronary heart disease [26].
However, further studies are needed to examine the value
of this approach and to demonstrate improvements in ob-
jective outcomes.
AIM
The aim of this study is to assess the impact of a smart-
phone-based secondary prevention program (SSPP), initi-
ated on discharge in patients with acute coronary
syndromes, on exercise capacity, cardiovascular risk
factors, quality of life and mood.
Hypothesis
The primary hypothesis is that a SSPP would improve
exercise capacity, as measured by a 6-minute walk test,
compared to standard care. Secondary hypotheses are: A
SSPP will result in improvement in cardiac depression
and quality of life scores as well as in cardiovascular risk
factors (lipid profile, blood pressure, HbA1C, anthropom-
etry) and secondary prevention pharmacotherapy use
between the groups.
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Methods/design
The study design is single-blinded, two-arm, parallel, ran-
domized control trial. The study design is displayed in
Fig. 1. The protocol conforms to the SPIRIT 2013 state-
ment and the intervention is described in accordance with
the CONSORT-EHEALTH checklist. [27–30]
Eligibility and recruitment
Patient over the age of 18 with a diagnosis of an acute
coronary syndrome and documented coronary artery
disease on coronary angiography (coronary artery sten-
osis >50 %), who are treated either medically or with
percutaneous coronary intervention will be eligible for
inclusion. The other major inclusion criteria will be
personal ownership of a smartphone.
Exclusion criteria include untreated ventricular tachy-
cardia, severe heart failure, significant residual coronary
artery disease requiring revascularization, treatment with
coronary artery bypass surgery, coexisting disease with a
life expectancy less than 1 year and/or significant exer-
cise limitations for reasons other than CHD.
Recruitment will occur during hospital admission at six
major university affiliated teaching hospitals in Victoria,
Australia. All patients admitted with acute coronary
syndromes will be screened and those meeting the
entry criteria will be selected. Potential participants will
receive study information and informed consent will be
obtained.
Sample size calculation
A sample size of 152 participants (76 per group) will be
required to detect a minimal clinically important differ-
ence of 25 m for the six-minute walk test with 80 % power
at 5 % level of significance [31, 32]. To account for an
estimated 20 % loss to follow-up, 100 patients in each
arm will be recruited.
Ethics approval
The Austin Health Human Research Ethics Committee
granted approval for the trial (HREC/14/AUSTIN/128).
Randomization and blinding
Eligible patients will be randomized in a 1:1 fashion to
smartphone-based secondary prevention program or usual
care through a computerized randomization program.
Randomization will be stratified by study site and be
overseen by the Centre of Cardiovascular Research and
Education in Therapeutics at Monash University; an in-
dependent research body within the School of Public
Health and Preventive Medicine at Monash University,
Melbourne, Australia. Baseline assessment, including the
6-minute walk test, will occur prior to randomization.
Assessors of the primary outcome are blind to treatment
allocation; however participants are not blinded.
Intervention
The smartphone-based secondary prevention program
will be delivered over 8 weeks starting at time of dis-
charge from hospital through a smartphone application
(app). Participants in the smartphone intervention cohort
will download the intervention application (“app”) into
their smartphone. They will then receive education on
how to use the app. The SSPP is a multi-faceted interven-
tion with particular emphasis on early physical activity.
The app provides a platform to deliver a comprehensive
secondary prevention program (Fig. 2). Participants can
Fig. 1 Randomized Control Trial Design and Flow
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log off the app at any time effectively not undertaking the
SSPP. The different components of the SSPP are dis-
cussed in detail below.
Exercise prescription
Patients will have access to real-time feedback of their
activity levels through the app’s activity tracker which
links to the smartphone’s accelerometer feature. Patients
will be able to monitor the number of steps taken and
the distance walked. Patients will undertake a graded
walking program increasing in time and intensity over the
8 weeks. Their aim will be to achieve 30 min of walking a
day for at least 5 days every week, in accordance with
guideline recommendations [3]. Patients will be encour-
aged to progress to moderate intensity activity, defined as
a noticeable increase in depth and rate of breathing while
still being able to talk comfortably, within 2 weeks.
Dynamic tracking of cardiovascular risk factors
Patients will have an interactive personal dashboard
highlighting the status of their cardiovascular risk factors.
Blood pressure, cholesterol levels, glucose levels, weight,
smoking status will be graded depending whether they are
at recommended target levels [3]. Patients will record this
information in the app prior to discharge and will be able
to update this at anytime.
Dietary habits
Dietary habits will be tracked through the app via ac-
cess to the phone’s inbuilt camera. Patients will be
Fig. 2 Smartphone application interface depicting interactive dashboard (a), cholesterol page (b), blood pressure progress chart (c), smoking education
page (d), photographic food diary (e), activity tracking page (f), individualized messaging service (g) and medication page (h)
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encouraged to photograph the food they consume. They
will have capabilities to rate and comment on the food
they are communing based on their perception of an ideal
diet as per guidelines.
Cardiac education
Two educational messages per week will be delivered to
the participants as they progress through the 8-week
SSPP.
Cardiac medication list
Patients will input their discharge medications into the
app prior to leaving hospital. The medication list will be
reviewed to ensure that appropriate evidence-based
pharmacotherapy (dual antiplatelet therapy, statin, angio-
tensin converting enzyme inhibitor/angiotensin receptor
blocker, beta-blocker) has been prescribed. If a particular
class of drug has not been prescribed, the patient will be
notified through the app and encouraged to discuss this
further with their cardiologist or general practitioner.
Participants will be able to edit their medication list
whenever a change is made.
Interactive and personalized feedback
Patients will receive five personalized messages per week
via the app messaging service. Two of the messages will
be educational and the remaining three messages pro-
vide goal setting and feedback on physical activity levels
and diet. The behavioural change strategies implemented
are based on social cognitive theory and have been previ-
ously successfully applied in mobile health technologies
[33]. There is emphasis on increasing confidence and
motivation to exercise while overcoming barriers to being
physically active. Furthermore, there is clear goal setting
prescribed every week regarding physical activity and diet.
Feedback is given based on exercise levels (automated)
and diet (personalized). The app allows the patient to
analyze their own physical activity and assess their pro-
gress towards their individualized goal. Table 1 shows
sample messages.
Support
The messaging service also allows the patient to initiate
contact if they have any questions regarding their car-
diac condition or rehabilitation process. Replies will be
made within one business day.
Standard care
Regardless of the treatment arm, all patients will receive
standard of care treatment post-ACS. This includes in-
patient cardiology review, pre-discharge planning, formal
communication with general practitioner through a dis-
charge summary letter, referral to cardiac rehabilitation,
promotion of self care and a chest pain action plan.
Outcome assessment
Participants will be evaluated at baseline, prior to dis-
charge from hospital, and at 8 weeks, as an outpatient.
The initial assessment will include explanation of study
protocol and signing of consent forms. Patients assigned
to SSPP will undertake app training to ensure they can
maximize their experience. Baseline evaluation will in-
clude measurement and assessment of height, weight,
waist circumference, resting heart rate and blood pres-
sure, smoking status, fasting cholesterol and glucose
levels and exercise capacity measured by a six-minute
walk test.
Primary outcome
The primary outcome is change in six-minute walk dis-
tance that will be measured in standardized fashion [34].
The initial test will be undertaken prior to hospital dis-
charge and this will be repeated at 8 weeks as an out-
patient, without monitoring.
Table 1 Sample Messages
Physical Activity
• Hi [name], walking is a great type of exercise for people with coronary
heart disease – I see you did xxxx steps yesterday. Over the next few
days, aim to walk at least 500 steps more a day!
• Hi [name], well done on your activity over the past week! For this
week, your goal is to walk for at least 20 min a day. Given your best
last week was xxxx steps, this week you should reach xxxx steps a day!
• Hi [name], well done on reaching xxxx steps last week! This week, your
aim is to walk 30 min a day everyday. Make it a routine as they
benefits will last a lifetime!
Dietary Habits
• Hi [name], diet is very important in reducing the risk of future heart
attacks. Your aim for the week is to try and eat 5 serving of vegetables
everyday. Make sure you take photos of your meals so you are
accountable for what you are eating!
• Hi [name], making small, healthy changes in the food and drinks that
you have can make a big difference. Over the next week can you try
and eliminate all soft drinks and junk food. Keep us posted with your
electronic food diary!
• Hi [name], did you know that oily fish contains polyunsaturated fat
that helps to lower your cholesterol? You should try and have 2–3
serves of fish each week.
Educational
• [Name], do you know what causes heart attacks? A heart attack occurs
when fatty material (or plaque) inside your coronary arteries ruptures.
Blood sticks together over the damaged area forming a clot that stops
flow to the heart muscle. If the blockage occurs for a long enough
period, heart muscle dies causing a heart attack.
• [Name], did you know it is essential to take your prescribed
medications? They will reduce your risk of further heart attacks, strokes
and premature death. You should be taking 5 medications for your
heart. Check with your doctor if you have any questions about them
or if need a new script – suddenly stopping your medications can
place you at high risk of further heart attacks.
• [Name], did you know most people can have sex soon after a heart
attack? If you can walk up two flights of stairs without getting
breathless or having chest pain, you are probably well enough to have
sex. If you have any concerns, don’t hesitate to contact your doctor.
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Secondary outcomes
In general, all secondary outcomes will be measured at
baseline and at 8-week follow-up. Table 2 summarises
the secondary outcomes of our study.
Body mass index will be derived from the weight (kg)
divided by height (m) squared. Waist circumference will
be measured using an anthropometric tape placed around
the participant’s waist at the level of the umbilicus. An
electronic sphygmomanometer with pulse oximetry will
be used to assess the systolic and diastolic blood pressure
as well as resting heart rate.
Fasting glucose and cholesterol levels will be measured
after 12 h of fasting. It will be analyzed at the pathology
department of the corresponding hospital in standard
fashion.
Smoking status, medication compliance and current
medication list will be assessed via self-reporting at the
8-week assessment. The date the participant returns to
work, if applicable, will also be collected to assess the time
to resumption of work after acute coronary syndromes.
Uptake, adherence and completion of a cardiac rehabili-
tation program will be assessed. Uptake is defined as at-
tending at least one exercise session for traditional cardiac
rehabilitation or uploading 1 day’s physical activity in the
SSPP. Adherence is defined as attending 4 weeks’ or
uploading 12-days of activity over 4 weeks of physical
activity. Completion is defined as showing adherence to
cardiac rehabilitation and attending the 8-week assess-
ment session.
Major adverse cardiovascular events (MACE) will be re-
corded. MACE is defined as the composite of death, myo-
cardial infarction, stroke and unplanned revascularization.
Assessment for depression will be undertaken with the
Cardiac Depression Scale (CDS) and Depression Scale –
Short Form (DS-SF) [35]. Assessment of anxiety will be
undertaken with the use of the Hospital Anxiety and
Depression Scale (HADS). Change in quality of life will
be assessed by the SF-36 questionnaire [36].
The EQ5D will be used to obtain a single preference
index for calculation of Quality Adjusted Life Years
(QALY) to assess cost per QALY for comparison to stand-
ard care. Health care utilization will be recorded for ad-
verse events including presentation to hospital and/or
general practitioner for symptoms of coronary heart
disease or heart failure.
Statistical analysis
Statistical analyses will be performed using SPSS (IBM,
USA). Baseline characteristics will be summarized using
descriptive statistics. Continuous variables will be described
as mean and standard deviation and be compared using
Student’s t test. Categorical variables will be described as
frequencies and percentages and compared using Fisher’s
exact or chi-square tests as appropriate. Treatment
evaluation will be performed on an intention to treat
(ITT) analysis.
Discussion
This novel study aims to evaluate the impact of a smart-
phone based secondary prevention program on functional
capacity of patients with acute coronary syndromes. The
benefit of comprehensive secondary prevention programs
incorporating physical activity is well recognised. Smart-
phone technology could hold the key to bridging the well
documented gap between scientific evidence and clinical
practice.
This randomised clinical trial also aims to build the sci-
entific base supporting alternative models of secondary
prevention care in patients post acute myocardial infarc-
tion. Of particular note, is the initiation of this program as
soon as the patient is discharged from hospital post their
index event. This is a crucial period of recovery and im-
mediate initiation of smartphone based secondary preven-
tion program may facilitate early physical activity and
return to normal daily function, including resumption of
work.
The primary endpoint aims to objectively assess im-
provement in physical activity through the use of the six-
minute walk test. Near maximal exercise testing is safe in
patients with uncomplicated myocardial infarction prior
to discharge and thus early mobilisation should be encour-
aged [37, 38]. The superiority trial design is suitable to de-
tect a minimal clinically important difference in 6-minute
walk distance [31]. It is postulated the improvement will
be due to earlier initiation of an exercise program and in-
crease in uptake and adherence with cardiac rehabiliation.
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Table 2 Primary and secondary endpoints
Primary Outcome
• Change in six-minute walk test distance
Secondary Outcomes
• Fasting lipid levels (TC, LDL-C, HDL-C, TG)
• Fasting glucose
• Resting blood pressure
• Weight and body mass index
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• Smoking status (self-reported)
• Uptake, Adherence and Completion of cardiac rehabilitation
• Major adverse cardiovascular events
• Cardiovascular hospital re-admissions
• Depression assessment (CDS and DS-SF questionnaires)
• Anxiety assessment (HADS questionnaire)
• Quality of life assessment (SF-36 questionnaire)
• Health outcome assessment (EQ-5D questionnaire)
• Time to return to work
• Secondary prevention pharmacotherapy use (self-reported)
• Six minute walk test distance at 8-weeks
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